Tag: teva
EU Probes Teva For Abuse Of Its Dominant Position
EU antitrust regulators are investigating Israeli drugmaker Teva over the possible abuse of its dominant position related to its multiple sclerosis medicine Copaxone, reported...
Failed Talks Between Teva & DOJ Proceeded Indictment
This week’s indictment of Teva Pharmaceutical Industries ’s US subsidiary on price-fixing charges came after a last-minute staredown with the Justice Department, reported The...
Teva Charged In US Price-Fixing Probe
Pharmaceutical group Teva has been charged in the US with conspiring to fix the price of generic drugs, including a common cholesterol treatment, after...
Teva’s Pay-For-Delay Antitrust Probe Gets Extra EU Objections
EU antitrust enforcers, boosted by recent court victories, on Monday, June 8, reinforced their case against Israeli drugmaker Teva over its deal with rival...
Israel’s Teva Pulls Out Of Settlement Talks With DOJ Over Price-Fixing...
Israel’s Teva Pharmaceuticals is said to have essentially “walked away” from settlement talks with the US Justice Department’s antitrust division in a high-profile lawsuit...
US: Teva settles with FTC
The Federal Trade Commission (FTC) has reached a settlement with Teva Pharmaceuticals Industries over charges that its agreements with rivals impeded consumer access to...
US: Humana sues generics manufacturers over price-fixing
Humana has brought a lawsuit against 37 pharmaceutical companies including Novartis, Mylan, and Teva, alleging price fixing of numerous generic drugs.
The conspiracy allegedly increased...
US: Pay-for-delay lawsuit settled for US$270m
Endo International Plc, Teva Pharmaceuticals and Teikoku Seijaku have agreed to pay a cumulative US$270.8 million to resolve class action lawsuits alleging Endo paid...
US: Teva faces new competition after FDA okays MSgeneric
Mylan NV's long-awaited US approval for its generic version of rival Teva's blockbuster multiple sclerosis treatment (MS) Copaxone drove the drugmaker's shares up more...
EU: Commission objects to Teva-Cephalon “pay-for-delay”
The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust...